Abstract
Background:
Anosognosia, or unawareness of symptoms, is common in Huntington’s disease (HD), but the neuroanatomical basis of this is unknown.
Objective:
To identify neuroanatomical correlates of HD anosognosia using structural MRI data.
Methods:
We leveraged a pre-processed dataset of 570 HD participants across the well-characterized PREDICT-HD and TRACK-HD cohort studies. Anosognosia index was operationalized as the score discrepancies between HD participants and their caregivers on the Frontal Systems Behavior Scale (FrSBe).
Results:
Univariate correlation analyses identified volumes of globus pallidus, putamen, caudate, basal forebrain, substantia nigra, angular gyrus, and cingulate cortex as significant correlates of anosognosia after correction for multiple comparisons. A multivariable model constructed with stepwise regression that included volumetric data showed globus pallidus volume alone explained more variance in anosognosia severity than motor impairment or CAP score alone.
Conclusions:
Anosognosia appears to be related to degeneration affecting both cortical and subcortical areas. Globus pallidus neurodegeneration in particular appears to be a key process of importance.
INTRODUCTION
Huntington’s disease (HD) is a neurodegenerative disease caused by a CAG trinucleotide repeat expansion in the huntingtin (Htt) gene. 1 Anosognosia, or unawareness of one’s symptoms, is a common symptom of HD. 2 Persons with HD can have anosognosia for symptoms across motor, behavioral, and cognitive domains. It is difficult to measure and often requires clinicians to compare patient history and exam with caregiver reports. Informant-based measurements, such as the Frontal Systems Behavior Scale (FrSBe), compare assessment results from patients and their informants (typically a caregiver).
Prior work has generally found that HD anosognosia correlates with the severity of other symptoms attributable to HD.3–9 Anosognosia can delay initiation of therapy and is associated with a higher caregiver burden, higher CAG burden, 10 and poorer executive function in HD. 11 Few studies have assessed HD-specific neuroimaging correlates of anosognosia. One prior report found that in the PREDICT-HD study, pre-symptomatic patients reported more executive dysfunction, apathy, and disinhibition than informants early on, but that this difference reversed later in the study, suggesting anosognosia develops slowly. 12 In the current study, we leveraged a large dataset of aggregated structural MRI and clinical assessments from the PREDICT-HD and TRACK-HD cohort studies to uncover clinical-imaging correlates of HD anosognosia.
METHODS
Study design
Deidentified data were procured from CHDI for the PREDICT-HD and TRACK-HD studies, including clinical assessments, demographic information, and structural MRI imaging data. PREDICT-HD subjects are premanifest at enrollment, whereas TRACK-HD participants may be premanifest or have early signs of HD. To capture the clinical-imaging correlates of interest, we used the last study visit & MRI scan data available for each participant to generate a cross-sectional dataset.
Volumetric MRI measurements
Structural MRI data were automatically segmented in MRICloud. 13 The MRICloud pipeline uses multi-atlas registration and a labeling fusion (MALF) algorithm to segment the whole brain in more than 200 regions of interest (ROIs), from which we extracted the volumes used in this study. Quality control (QC) was performed on original images and segmentation results, but no human correction of the segmentation was performed to avoid bias and to guarantee reproducibility in other independent large samples. The full list of ROIs is provided as part of our results reporting in Supplementary Table 1. Prior to use in analysis, all individual volumes were normalized to whole-brain volume (WBV, i.e., intracranial volume minus cerebrospinal fluid) to account for volumetric changes relative to total parenchymal volume. Data used to support the results of this investigation will be provided to investigators following reasonable request and discussion. Further details have been described in our previous work. 14 QC failure rates were similar between PREDICT-HD (2.2%) and TRACK-HD (1.5%).
Clinical assessments and calculations
To measure anosognosia in the present study, we compared participant- and companion-rated scores on the Frontal Systems Behavior Scale (FrSBe). 15 The FrSBe scale has three subscales: executive dysfunction, disinhibition, and apathy. Each subscale includes items rated on a 5-point Likert scale describing symptom frequency ranging from “almost always” to “almost never.” Anosognosia was operationalized as the difference between companion- and participant-rated scores for the full FrSBe scale, such that higher values correspond to worse ratings by companions (i.e., anosognosia).
CAP (CAG×Age product) score was calculated as CAP = Age×(CAG repeat length – 33.66). 16 It estimates the cumulative exposure to CAG repeat expansion over time. We used previously validated depression scale cutoffs for the Hospital Anxiety and Depression Scale (HADS) and Beck Depression Inventory-II (BDI-II) to group participants as depressed or not depressed (HADS ≥7, BDI-II ≥11). 17
Statistical analysis
All statistical analysis was performed in R 4.2.2. 18 Spearman’s rank correlation coefficient (rho) was used to measure correlation strength between anosognosia and whole brain-normalized ROI volumes. 14 The Holm method was used to correct correlation p-values for multiple comparisons (i.e., the 44 brain ROI volumes tested). Statistical significance was set at α=0.05.
Forward stepwise variable selection was implemented to identify the brain volume ROIs that collectively produce the most informative regression model of anosognosia. This was accomplished in a criterion-guided manner using the Akaike information criterion (AIC). All models were adjusted for participant sex. CAP score and age were not included due to very high collinearity with various brain ROI measures and the normalization measure (WBV), but a separate sex & CAP score-only model was produced for purposes of comparison.
RESULTS
Characteristics of the TRACK-HD and PREDICT-HD participants who were included in the present analysis are described in Table 1, including the total FrSBe score and subscales. Companion-participant score difference (‘Anosognosia Index”) means and standard deviations for the total FrSBe score (–3.5±23.7) and subscales of executive dysfunction (–0.9±11.6), apathy (–0.5±7.8), and disinhibition (–2.1±7.2) indicated significant variation that was approximately normal in distribution (Supplementary Figure 1).
Characteristics of study population (n = 570)
Sample size is 570 except for UHDRS motor score (n=561), UHDRS TFC (n=557), HADS depression (n=196, TRACK-HD only), BDI-II (n=146, PREDICT-HD only). *T-test results for companion-participant score differences: Total score (t=2.2, p=0.031), Executive dysfunction (t=1.2, p=0.213), Apathy (t=0.85, p=0.395), Disinhibition (t=4.80, p<0.0001). SD, standard deviation; UHDRS, Unified Huntington Disease Rating Scale; HADS, Hospital Anxiety and Depression Rating Scale; BDI-II, Beck Depression Inventory-II; FrSBe, Frontal Systems Behavior Scale.
To test whether we could identify structural MRI correlates of anosognosia, we performed a correlation analysis between anosognosia scores and 44 brain ROI volumes. As presented in Table 2, this analysis revealed significant inverse relationships between anosognosia and brain volume in key basal ganglia regions affected in HD (globus pallidus, putamen, caudate). Additionally, anosognosia correlated with reduced volume in basal forebrain, substantia nigra, and angular gyrus, as well as relatively preserved volume (the relative “increase” indicating absence of volume loss) in cingulate cortex (Table 1). A full list of correlation results is presented in Supplementary Table 1. We also estimated the relative changes in volume present for patients with a relatively high degree (top 25th percentile) of anosognosia (Supplementary Table 2). Consistent with prior studies, anosognosia correlated with motor impairment, though with a correlation coefficient of ρ= 0.17 (p < 0.0001).
Correlations between anosognosia and whole-brain normalized MRI volumes
Correlation between the total FrSBe companion-participant score difference (anosognosia) and each brain ROI volume was tested using the Spearman’s correlation coefficient (rho). p-values were adjusted for multiple comparisons with the Holm method. df, degrees of freedom.
To identify brain regions that may be most useful collectively as volumetric markers of anosognosia, we performed linear regression with stepwise ROI variable addition. This procedure generated a list of 6 regions (Table 3) that contributed to a final model of anosognosia with the lowest loss of information, as determined by the AIC criterion. The final model has an adjusted R2 of 7.4%, which is notably higher than a model that includes only CAP score (2.7%).
Stepwise forward regression of anosognosia with regional MRI volumes
“Variance explained” is defined as adjusted-R2 for the whole model. “Additional variance” refers to the increase in adjusted-R2 conferred by addition of the corresponding brain region. The first model contains no brain region variables other than globus pallidus; all models are adjusted by sex as a covariate. All model F-statistics are statistically significant to p <10-7 or smaller, except the CAP-only model (p=0.0001). df, degrees of freedom.
We also considered that depression may influence self-reported symptom severity, i.e., that more depressed patients could have more negative self-assessments and reduced score differences with participants. To test this possibility, we compared companion-participant FrSBe score differences among patients with or without depression, as determined using validated cutoffs for the HADS and BDI-II scales used in TRACK-HD and PREDICT-HD respectively. In the subset of participants (n = 342) with depression scores collected, we found that 73 (21%) met cutoffs for depression. As depicted in Supplementary Figure 2, depressed participants were more likely to rate their impairment more highly relative to companions than were non-depressed participants (mean companion-participant difference = –9.56, t = 3.09, df = 340, p = 0.002). To determine whether participants reporting much worse symptoms than their companions could be biasing results, we repeated the correlation analysis summarized in Table 2, excluding participants in the bottom quartile of companion-participant score discordance (i.e., symptom “over-estimators”). The result (Supplementary Table 3) demonstrates that, generally, exclusion of these participants did not reduce the strength of correlations; in most cases, correlation strength increased.
DISCUSSION
In this study we identified several volumetric MRI correlates of HD anosognosia using two well-characterized datasets, PREDICT-HD and TRACK-HD. Specifically, volumes of globus pallidus (GP), putamen, caudate, basal forebrain, substantia nigra, angular gyrus, and cingulate cortex significantly correlated with anosognosia. Further, we provide evidence through multivariable modeling that the variance in anosognosia severity can be explained better by structural MRI data than CAP score or motor symptomatology alone.
Clinically, anosognosia poses a significant challenge to patients with HD and their family. Differences in understanding about symptom severity can create dangerous scenarios; for example, a patient may need to stop engaging in previously normal tasks, such as driving, that are no longer safe for them. These barriers to mutual understanding can also compound with co-existing neuropsychiatric challenges, such as irritability and depression. Thus, a better understanding of anosognosia in HD is not only of scientific interest, but urgent clinical need. We would suggest, based on our data, that it would be helpful for families to understand that anosognosia is not simply a “denial” of one’s symptoms, but rather an intrinsic aspect of HD caused by neurodegeneration.
HD neuropathology studies have generally focused more on the striatum than GP. 19 Our univariate correlation data suggest that GP degeneration is at least as important to HD anosognosia as striatum. In the context of multivariate regression, GP volume was included first by the stepwise regression algorithm, instead of other basal ganglia structures, suggesting that the GP captures the most overall variance in anosognosia severity. Various other regions that did not correlate very strongly with anosognosia at a univariate level, such as the superior occipital gyrus, were selected by the stepwise algorithm as well. This may indicate that these regions contribute some additional explanatory value for the anosognosia measure that is derived from extrastriatal degeneration and impacts on circuit-level function.
Existing knowledge of anosognosia mechanisms largely derives from lesion studies (i.e., parietal cortex), investigation of the neurological basis of consciousness, and research on Alzheimer disease.20,21, 20,21 Of particular current interest is the default mode network (DMN), which may hold relevance for anosognosia within and beyond the context of HD. DMN function is associated with self-referential thinking and internally generated thought, i.e., cognitive content that appears to arise independently of external stimuli (e.g., “mind-wandering”). Interestingly, structures identified by our study as associated with anosognosia, namely the angular gyrus and cingulate cortex, are key nodes of the DMN. 22 It has been suggested that angular gyrus, posterior cingulate cortex, and medial prefrontal cortex are the three core regions that link subcircuits of the DMN and are most regularly engaged as the self-referential components of the DMN. 22 The GP and putamen have also been proposed to be key subcortical sites enabling DMN function. 23 However, our results can only draw attention to relative differences in volume in these regions among HD participants with anosognosia and cannot be interpreted as mechanistic evidence for the presence of dysfunctional DMN nodes.
We acknowledge some limitations of our analysis. Volumetric estimates of small regions that were significant in our results, such as basal forebrain, are less reliable than those of larger brain areas. 24 Similarly, cingulate cortex volume estimates are vulnerable to segmentation errors that over-estimate volume due to its complex mid-sagittal anatomy. 25 The participant-companion discrepancy method of anosognosia measurement employed herein may entail over- or under-reporting. For example, the companion is often a caregiver, a role that can be felt as emotionally straining and stressful. Their reporting may be impacted by their own perceptions about how well-controlled the HD symptoms are, even if the person with HD has an objectively accurate notion of their symptomatology. However, caregiver scores are generally more closely aligned with objective ratings than patient-reported measures, suggesting this discrepancy is likely to be generally reliable. 9 Future work may employ targeted scales of anosognosia that are designed to minimize error related to reporting biases and control for the impact of co-existing affective disorders or non-specific attentional impairment. Such measures, particularly by incorporating assessment of cognition, could operationalize anosognosia more specifically than a linear measure of caregiver-participant incongruence as employed here. It is also important to note that the GP is a prominent structure associated with anosognosia due to its high degree of atrophy correlation with the striatum in HD. 14 The multivariate analyses therefore identified brain regions that make best model when combined with other covariates.
In conclusion, the present work identifies key structural MRI correlates of anosognosia in HD. In particular, our finding that the GP is a key volumetric correlate of anosognosia may motivate further investigation of this region specifically. We anticipate that future studies employing other imaging modalities (e.g., functional MRI) and more specific measures of anosognosia may provide further information about the circuit-level dysfunction related to HD anosognosia.
Footnotes
ACKNOWLEDGMENTS
The authors have no acknowledgements to report.
FUNDING
Supported by the National Institute of Neurological Disorders and Stroke NS102670-01A1 and NS086452-06 (plus grants supporting the generation of the original datasets, as noted in their publications cited). Additional funding include R01NS086452 and grant from the JHU HD Precision Medicine Center of Excellence.
CONFLICT OF INTEREST
Funding for the study was provided by the NIH under a license agreement between AnatomyWorks LLC and the Johns Hopkins University. Dr. Michael I. Miller and the University are entitled to royalty distributions related to technology described in the study. Dr. Miller is a founder of and holds equity in AnatomyWorks LLC. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. The other authors declare no relevant conflicts of interest.
JTH receives tuition and stipend support through the Medical Scientist Training Program at the Johns Hopkins School of Medicine (NIH/NIGMS T32GM007309) and through the National Institute on Aging (F30AG067643).
DATA AVAILABILITY
The study is ongoing with the images still under analysis. The individual brain regional volumetric data reported here will be provided to qualified investigators upon request and discussion.
